Pediatrics Articles

Pediatrics

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sutton R et al. – Study concludes a strong predictive value of minimal residual disease (MRD) kinetics at day 15; should be validated in a larger patient cohort so that earlier detection of risk of relapse can be assessed. In addition, data also provide evidence that additional late MRD monitoring of patients would enable detection of molecular relapse, which, in combination with salvage therapy, may provide the means to further improve survival rates in children with acute lymphoblastic leukaemia (ALL).

Methods

Results


Today in Pediatric Heme/Oncology...keeping you current

Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: A therapeutic advances in Childhood Leukemia Consortium Study
Journal of Clinical Oncology, 10/22/09

Medulloblastoma in childhood: revisiting intrathecal therapy in infants and children
Cancer Chemotherapy and Pharmacology, 10/29/09

Genetics: Newborn screening for sickle cell anemia
Canadian Family Physician, 10/14/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address